RARE
Ultragenyx Pharmaceutical Inc.
Nasdaq Pharmaceutical Preparations Large accelerated filer

Key Financials

Net Income
$-575000000
↓ 1.0%
Revenue
$673.0M
↑ 20.1%
Operating Income
$-535000000
↑ 0.2%
EPS (Diluted)
$-5.83
↑ 7.3%
Total Liabilities
$1.6B
↑ 29.3%
Cash & Equivalents
$421.0M
↑ 142.3%
Shareholders' Equity
$-80000000.00
↓ 131.3%
Total Assets
$1.5B
↑ 1.9%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G 8/14/2026 View on SEC
SCHEDULE 13G 8/13/2026 View on SEC
8-K 8/11/2026 View on SEC
SCHEDULE 13G 8/7/2026 View on SEC
10-Q 8/5/2026 View on SEC
8-K 8/4/2026 View on SEC
4 8/4/2026 View on SEC
4 8/4/2026 View on SEC
144 8/3/2026 View on SEC
SCHEDULE 13G/A 7/31/2026 View on SEC

Company Information

Field Value
Ticker RARE
Company Name Ultragenyx Pharmaceutical Inc.
CIK 1515673
Sector Pharmaceutical Preparations
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 415-483-8800